retatrutide clinical trials latest This data from Phase 3 for was announced yesterday at @amdiabetesassn #ADA2026 ✓ We are fortunate to be living in a time where there multiple medications which safely reduce Drug retatrutide helps people lower

These patients often experience multiple comorbidities, such as diabetes and cardiovascular disease, where GLP-1 therapies offer additional health benefits beyond weight loss

Nutritional priorities to support GLP-1 therapy for obesity: A joint advisory (2025) ACLM, ASN, OMA, TOS GLP-1 Dietary Recommendations for Management of Gastrointestinal Symptoms in Patients on GLP-1 Receptor Agonist Therapy (2024) Dietary intake by patients taking GLP-1 and dual GIP/GLP-1 receptor agonists (2024) GLP-1

Until similar data exists for Retatrutide, there remains an open question about its cardiovascular safety and potential benefit, particularly given the theoretical cardiovascular considerations around glucagon receptor activation

Others experience immediate appetite changes

- Snacks - I don't keep a lot of snacks in the house, but 2-3x a week I would go to Publix for some snacks

Congratulations